Seeking Alpha

Credit Suisse warns that a sale of Dendreon (DNDN -0.7%) is not likely in the near-term, and...

Credit Suisse warns that a sale of Dendreon (DNDN -0.7%) is not likely in the near-term, and said it doesn't appear that any major players are interested in acquiring the company. The firm adds that Dendreon has been quietly reorganizing its business development team and believes its head, David Ghesquiere, left the company over a week ago.
Comments (2)
  • does he believe or know for sure if David Ghesquiere has left the company and for what reason?
    26 Jun 2012, 04:48 PM Reply Like
  • Wow, it is not likely, yet possible. May or may not happen. What actionable advice. Did Davie leave? Did he do a good job? Perhaps he deserved to be let go. Does it make sense that BP would not be interested in new ways to treat cancer? I would love to know Credit Swiss' trading position in the company. Just BS.
    26 Jun 2012, 06:15 PM Reply Like
DJIA (DIA) S&P 500 (SPY)